FDA Adverse Event Injury Summary report: N

BONE WAX UNKNOWN PRODUCT

MDR report key: 16896143 · Received May 9, 2023

Report

Report Number
2210968-2023-03470
Event Type
Injury
Date Received
May 9, 2023
Date of Event
February 22, 2021
Report Date
May 9, 2023
Manufacturer
ETHICON INC.
Product Code
MTJ
PMA / PMN Number
PRE-AMEND
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? WHICH SPECIFIC ETHICON PRODUCTS HAVE BEEN USED DURING THE PROCEDURES (PRODUCT CODE, LOT NUMBER)? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. H6 COMPONENT CODE: G07002 ¿ DEVICE NOT RETURNED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. RELATED EVENTS REPORTED VIA 2210968-2023-03469 AND 2210968-2023-03471. CITATION CITE: J NEUROL SURG B SKULL BASE 2022;83:185¿192. DOI HTTPS://DOI.ORG/10.1055/S-0040-1721815.

Description of Event or Problem · 0

TITLE: RETROSIGMOID CRANIECTOMY WITH A LAYERED SOFT TISSUE DISSECTION AND HYDROXYAPATITE RECONSTRUCTION: TECHNICAL NOTE, SURGICAL VIDEO, REGIONAL ANATOMY, AND OUTCOMES. THE AIM OF THIS STUDY WAS TO REPORT THE TECHNICAL NUANCES DEVELOPED BY TWO SENIOR SKULL BASE SURGEONS FOR RETROSIGMOID CRANIECTOMY WITH RECONSTRUCTION AND PROVIDE ANATOMIC DISSECTIONS, THE REGIONAL SOFT TISSUE AND BONY ANATOMY AS WELL AS THE STEPS FOR OUR RETROSIGMOID CRANIECTOMY WERE RECORDED WITH PHOTOGRAPHS, ANATOMIC DISSECTIONS, AND VIDEO. RECORDS FROM 2017 TO 2019 WERE REVIEWED TO DETERMINE THE INCIDENCE OF COMPLICATIONS AFTER THE AUTHORS BEGAN USING THE DESCRIBED APPROACH. THE INFERIOR BONY REMOVAL EXTENDS TOWARD BUT NOT INTO THE FORAMEN MAGNUM. MASTOID AIR CELLS ARE SEALED WITH ABSORBABLE BONE WAX. FOR CLOSURE A DURAL XENOGRAFT IS FREQUENTLY REQUIRED AND IS SUTURED IN PLACE WITH 4¿0 BRAIDED NYLON SUTURE (NUROLON, JOHNSON & JOHNSON) ,THE TWO FASCIAL INCISIONS ARE THEN CLOSED WITH INTERRUPTED SUTURED TECHNIQUE USING 2¿0 ABSORBABLE SUTURE (VICRYL, JOHNSON & JOHNSON). THE SKIN FLAP IS TURNED DOWN OVER THE REPAIR AND THE SUBCUTANEOUS TISSUE AND GALEAL CLOSED WITH A RUNNING 2¿0 ABSORBABLE STITCH (VICRYL, JOHNSON & JOHNSON) REPORTED COMPLICATIONS INCLUDED PSEUDOMENINGOCELES (N=4) , CSF RHINORRHEA (N=2) , WOUND INFECTION(N=1), ASEPTIC MENINGITIS (N=1) IN CONCLUSION THE RELEVANT REGIONAL ANATOMY AND A REVISED TECHNIQUE FOR RETROSIGMOID CRANIECTOMY WITH RECONSTRUCTION HAVE BEEN PRESENTED WITH ACCEPTABLE RESULTS. READERS CAN CONSIDER THIS TECHNIQUE WHEN USING THE RETROSIGMOID APPROACH FOR PATHOLOGY IN THE CEREBELLOPONTINE ANGLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
726579 BONE WAX UNKNOWN PRODUCT WAX, BONE MTJ ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention